Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. (2014)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(14)70361-4
PubMed Identifier: 25163905
Publication URI: http://europepmc.org/abstract/MED/25163905
Type: Journal Article/Review
Volume: 15
Parent Publication: The Lancet. Oncology
Issue: 10
ISSN: 1470-2045